You are here
,

Immunomedics' cancer treatment fails to win accelerated approval from the FDA

  • Tuesday, 22 January 2019
  • Posted by Aftab Ahmad
  • 0 Comments
Immunomedics Inc said on Thursday the U.S. Food and Drug Administration declined to grant accelerated approval for its breast cancer treatment, sacituzumab.


from Reuters: Health News https://reut.rs/2R0iMGc

Aftab Ahmad

We are.., This is a short description in the author block about the author. You edit it by entering text in the "Biographical Info" field in the user admin panel.

No comments:

Leave a Reply